Hattar Industrial Estate’s Role In Pharmaceuticals

Established in the mid-80s in the province of Khyber Pakhtunkhwa, Hattar Industrial Estate (HIE) represents a pivotal advancement in the country’s industrial landscape. HIE, recognised as a special economic zone by Pakistan’s Federal Board of Investment, spans 1443 acres, making it one of Khyber Pakhtunkhwa's major manufacturing hubs with over 400 operational units. 

This designation and its vast area reflect a strategic effort to enhance the heavy industries of Pakistan (e.g., chemicals, glass, steel, cement, and textiles) by leveraging its prime location and high-quality infrastructure to ignite industrial growth, employment opportunities, and foreign investments.

Among its thriving sectors, the pharmaceutical sector stands out. With HIE as a catalyst, Pakistan's pharmaceutical industry has flourished, achieving a valuation of Rs. 748 billion and witnessing a robust growth rate of 15.3% over the last five years, per reports by the Institute of Chartered Accounts of Pakistan.

This vibrancy emphasises HIE’s vital role in amplifying pharmaceutical production and boosting Pakistan’s industrial success story on the global map.

Let's dive deeper into how the Hattar economic zone powers the country’s pharmaceutical manufacturing industry.

The pharmaceutical industry at Hattar Industrial Estate

The Hattar Industrial Estate is a critical hub for pharmaceutical companies in Pakistan, enabling innovative advancements and ensuring a steady supply of quality healthcare products. Here’s a quick list of notable pharmaceutical companies in Hattar:

• Cherwel Pharmaceuticals
• Cirin Pharmaceuticals
• Genome Pharmaceuticals Pvt Ltd
• Lucky Core Industries Limited
• Sayyed Pharmaceuticals
• SPL Pharmaceuticals Pvt Ltd
• Welmark Pharmaceuticals

These manufacturers are at the forefront of pharmaceutical production within the Hattar economic zone, specialising in producing general medications, including analgesics, anti-allergics, antibiotics, anti-infectives, anxiolytics, as well as injectables for treating various infections, among others.

Their operations not only support the domestic healthcare system but also contribute to the growth of Pakistan's pharmaceutical industry, helping to establish the nation as a formidable entity on the global stage. 

Economic impact and export potential of Hattar’s pharmaceutical products

While in its developmental phase, Pakistan's pharmaceutical industry is gradually marking its presence in the Asia-Pacific market, evidencing the potential for broader economic impact and export growth. 

In Hattar, standout companies like Genome Pharmaceuticals are showcasing Pakistan's capability on the international stage, with significant exports of pharmaceutical products to Afghanistan, Cambodia, Myanmar, Sri Lanka, and Vietnam. Positioned for growth, they aim to extend their reach into the Commonwealth of Independent States (CIS) countries.

Similarly, the quality and reliability of products from Sayyed Pharmaceuticals have facilitated entry into competitive markets such as Afghanistan, Burundi, Kenya, and Sierra Leone in West Africa. 

These developments highlight the critical role of Hattar Industrial Estate in enhancing Pakistan's pharmaceutical sector.

Moreover, government incentives in the country have played a pivotal role in supporting this upward trajectory. To foster innovation and ensure high standards in pharmaceutical production, the government has introduced a reduced sales tax rate of 1% on importing raw materials used in the primary manufacturing of pharmaceuticals. Additionally, a 0% duty on the import of Active Pharmaceutical Ingredients (APIs), packaging materials, diagnostic kits, and equipment further lays the groundwork for the sector's advancement.

These strategic initiatives are crucial for the growth of Hattar's import and export of pharmaceutical products, enabling it to expand its business operations effectively. Such developments indicate promising growth for Pakistan's pharmaceutical industry, which, through increasing global exports, further strengthens the national economy.

Challenges and opportunities

Despite the presence of thriving pharmaceutical and other manufacturing companies within Hattar Industrial Estate, several operational challenges could potentially slow its growth trajectory. Some of these challenges include:

• Securing consistent investment: Vital for the expansion and modernisation of facilities.
• Fluctuating utility supply: Electricity and gas supply inconsistencies affect pharmaceutical production schedules and efficiency.
• Workforce safety and welfare: Ensuring the health and safety of employees is crucial for productivity but necessitates dedicated resources and comprehensive policies.

Moreover, Hattar faces stiff competition from other industrial economic zones in Pakistan, such as Faisalabad Industrial Estate Development and Management Company (FIEDMC) and Quaid-e-Azam Industrial Estate (QIE). These competitors offer the highest level of international infrastructure, have uninterrupted power supplies, and efficient logistics, drawing potential investors away from Hattar.

Despite these hurdles, Hattar Industrial Estate holds significant opportunities for expansion and innovation that can redefine its market position and contribute to its growth:

• Leveraging strategic location for exports: Hattar's proximity to vital trade routes positions it uniquely as a potential export nexus, especially for pharmaceuticals and chemicals, particularly for Central Asian markets and beyond.
• Targeting renewable energy integration: By incorporating renewable energy solutions into its operations, Hattar can reduce its carbon footprint and energy costs, making it an attractive site for eco-conscious investors.
• Advanced waste management solutions: Developing state-of-the-art waste treatment and recycling facilities could address local environmental concerns and set a benchmark for industrial sustainability in Pakistan.

• Reliable logistics partnerships: Establishing partnerships with reliable logistics providers to ensure efficient distribution and supply chain management, enhancing Hattar's appeal as a manufacturing and export hub.

Embracing these opportunities, Hattar Industrial Estate can transform its challenges into stepping stones for innovation and enhanced global standing.

Hattar Industrial Estate’s gateway to global pharmaceutical success